The effect of a new non-steroidal anti-inflammatory agent, sulindac, on platelet function.
D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology; D001241:Aspirin / Q000494:pharmacology; D001597:Benzylidene Compounds / Q000494:pharmacology*; D001792:Blood Platelets / Q000378:metabolism / Q000502:physiology; D002846:Chromatography, Affinity; D002986:Clinical Trials as Topic; D006801:Humans; D007192:Indenes / Q000494:pharmacology*; D007213:Indomethacin / Q000494:pharmacology*; D010974:Platelet Aggregation / Q000187:drug effects*; D012701:Serotonin / Q000378:metabolism
D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D001597:Benzylidene Compounds; D007192:Indenes; D012701:Serotonin; D001241:Aspirin; D007213:Indomethacin